I do think this requires more explanation from CSL. They bought Ruide because plasma derived therapies (apart from Albumin) can’t be imported into China. China plasma derived market was meant to be fast growing. You’d think this is CSL’s core business. The asx release explanation for this sale tells us nothing.
I do think this requires more explanation from CSL. They bought...
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$285.29 |
Change
1.900(0.67%) |
Mkt cap ! $138.1B | |||
| Open | High | Low | Value | Volume |
| $286.24 | $286.95 | $283.70 | $138.5M | 483.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 79 | $285.29 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $285.40 | 112 | 2 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| CSL (ASX) Chart |